Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
GI Eosinophilic Disorders
Do you use asthma or EoE dosing if initiating dupilumab in a patient who meets criteria for treatment for both disorders?
Answer from: at Community Practice
I would do the higher dose (EoE) if starting it for both.
Sign in or Register to read more
23638
Related Questions
Is there a role for use of dupilumab for hypereosinophilic GI disorders distal to the esophagus?
Is there a role for anti-IL5 therapy in the treatment of EoE?
Do you believe that pretreatment with montelukast or other LTRAs can reduce the risk of urticaria or angioedema with NSAIDS?
How often do you rely on using the C1 inhibitor functional assay versus quantitative level alone to diagnosis HAE?
Does a diagnosis of NARES change your management of rhinitis?
How do you approach performing a food challenge in a patient with CSU who is dependent on their H1 blockers?
How do you decide when to add a second biologic agent to a patient’s asthma treatment who has either not responded or had a partial response to dupilumab, omalizumab, mepolizumab, or tezepelumab?
What is your experience managing patients with chronic spontaneous urticaria occurring only at night?
How do you perform patch testing in patients who are allergic to adhesives?
Is methacholine challenge on its way out?